UK government snubs GSK in favour of rival RSV shot from Pfizer
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
MODERNA gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it ...
GSK's vaccine is the first for RSV to be approved AFP The United States on Wednesday approved the world's first ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.